Al Ahly Capital signs to buy El Sewedy’s 40% of CIRA’s Damietta university venture
Plus: Rameda board greenlights plan for an all-share acquisition of Art Pharma subject to independent valuation
Available in your choice of English or Arabic
Plus: Rameda board greenlights plan for an all-share acquisition of Art Pharma subject to independent valuation
Queue